Toggle Nav

Fosmidomycin (sodium salt)

Catalog No.
C4898
A gram-negative and gram-positive antibiotic
Grouped product items
SizePriceStock Qty
5mg
$185.00
Ship with 5-10 days
10mg
$348.00
Ship with 5-10 days
25mg
$739.00
Ship with 5-10 days

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

1-deoxy-d-xylulose 5-phosphate reductoisomerase is an enzyme that interconverts DXP and 2-C-methyl-D-erythritol 4-phosphate (MEP) [2].

Fosmidomycin was active against both Gram-negative and Gram-positive bacteria and the human malarial parasite P. falciparum with the IC50 of 290-370 nM[3]. Fosmidomycin inhibited 1-deoxy-d-xylulose 5-phosphate reductoisomerase in an alternative nonmevalonate pathway for terpenoid biosynthesis with IC50 of 8.2 nM [1]. Fosmidomycin has been shown to possess activity against Plasmodium falciparum in vitro and in the mouse model. In patients with acute uncomplicated Plasmodium falciparum malaria, oral administration of 1,200 mg fosmidomycin every 8 h for 7 days was effective in curing uncomplicated Plasmodiumfalciparum malaria in humans [4]. Fosmidomycin was an effective and safe antimalarial drug [4]. The treatment was well tolerated and showed a fast parasite and fever clearance [4].

References:
[1] Kuzuyama T, Shimizu T, Takahashi S, et al.  Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis[J]. Tetrahedron letters, 1998, 39(43): 7913-7916.
[2] Takahashi S, Kuzuyama T, Watanabe H, et al.  A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis[J]. Proceedings of the National Academy of Sciences, 1998, 95(17): 9879-9884.
[3] Jomaa H, Wiesner J, Sanderbrand S, et al.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs[J]. Science, 1999, 285(5433): 1573-1576.
[4] Lell B, Ruangweerayut R, Wiesner J, et al.  Fosmidomycin, a novel chemotherapeutic agent for malaria[J]. Antimicrobial agents and chemotherapy, 2003, 47(2): 735-738.

Chemical Properties

Physical AppearanceA crystalline solid
StorageStore at -20°C
M.Wt205.1
Cas No.66508-37-0
FormulaC4H9NO5P·Na
SynonymsAntibiotic FR31564,FR31564
Solubility≤5mg/ml in PBS, pH 7.2
Chemical NameP-[3-(formylhydroxyamino)propyl]-phosphonic acid, monosodium salt
SDFDownload SDF
Canonical SMILESON(C([H])=O)CCCP([O-])(O)=O.[Na+]
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Protocol

Cell experiment [1]:

Cell lines

P. falciparum strains

Preparation method

The solubility of this compound in PBS is ≤ 5mg/ml, pH 7.2. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

45nM~370nM

Applications

Fosmidomycin is active against three different Plasmodium falciparum strains (HB3, A2, and Dd2) with IC50 values of 45nM to 370nM.

Animal experiment [1]:

Animal models

Mice infected with the rodent malaria parasite P. vinckei

Dosage form

10 mg/kg (i.p.)

Application

With intraperitoneal injection of fosmidomycin greater than 10 mg / kg, the animals were apparently free of parasites. Treated with 5 mg / kg fosmidomycin, parasitemia was <1%. Animals treated with 50 or 100 mg / kg fosmidomycin for oral administration apparently is free of parasites, and parasiteemia was <1% after treatment with the 20 mg / kg drug.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Türbachova I, Eberl M, Zeidler J, Lichtenthaler HK, Soldati D, Beck E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science. 1999 Sep 3;285(5433):1573-6. PubMed PMID: 10477522.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

Fosmidomycin (sodium salt)